Kim MC - Search Results

1

A 32-year-old man with plexiform schwannoma of the thyroid gland: a case report.

Park IR, Kim MC, Chung SM, Song SY. Park IR, et al. Among authors: kim mc. J Yeungnam Med Sci. 2024 Oct;41(4):312-317. doi: 10.12701/jyms.2024.00556. Epub 2024 Sep 10. J Yeungnam Med Sci. 2024. PMID: 39307573 Free PMC article.

2

Extraspinal sacrococcygeal myxopapillary ependymoma in a teenager.

Kim M, Gu MJ. Kim M, et al. J Yeungnam Med Sci. 2023 Oct;40(4):454-456. doi: 10.12701/jyms.2022.00367. Epub 2022 Sep 2. J Yeungnam Med Sci. 2023. PMID: 36052420 Free PMC article. No abstract available.

3

NDRG3 protein expression is associated with aggressive biologic phenotype and unfavorable outcome in patients with invasive breast cancer.

Kim MC, Park MH, Kang SH, Bae YK. Kim MC, et al. Int J Clin Exp Pathol. 2019 Oct 1;12(10):3886-3893. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933778 Free PMC article.

4

Characteristics and Prognosis of Estrogen Receptor Low-Positive Breast Cancer.

Kim MC, Park MH, Choi JE, Kang SH, Bae YK. Kim MC, et al. J Breast Cancer. 2022 Aug;25(4):318-326. doi: 10.4048/jbc.2022.25.e31. Epub 2022 Jun 29. J Breast Cancer. 2022. PMID: 35914748 Free PMC article.

5

Impact of immunohistochemistry staining conditions on the incidence of human epidermal growth factor receptor 2 (HER2)-low breast cancer.

Kim MC, Kwon SY, Jung HR, Bae YK. Kim MC, et al. Virchows Arch. 2024 May 17. doi: 10.1007/s00428-024-03824-6. Online ahead of print. Virchows Arch. 2024. PMID: 38758231

6

Impact of the Updated Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer.

Kim MC, Kang SH, Choi JE, Bae YK. Kim MC, et al. J Breast Cancer. 2020 Oct;23(5):484-497. doi: 10.4048/jbc.2020.23.e53. J Breast Cancer. 2020. PMID: 33154824 Free PMC article.

7

Prediction of Oncotype DX Recurrence Score Using Clinicopathological Variables in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

Kim MC, Kwon SY, Choi JE, Kang SH, Bae YK. Kim MC, et al. J Breast Cancer. 2023 Apr;26(2):105-116. doi: 10.4048/jbc.2023.26.e19. J Breast Cancer. 2023. PMID: 37095618 Free PMC article.

8

CD9 Expression in Colorectal Carcinomas and Its Prognostic Significance.

Kim KJ, Kwon HJ, Kim MC, Bae YK. Kim KJ, et al. Among authors: kim mc. J Pathol Transl Med. 2016 Nov;50(6):459-468. doi: 10.4132/jptm.2016.10.02. Epub 2016 Oct 25. J Pathol Transl Med. 2016. PMID: 27780340 Free PMC article.

9

Coexistent Loss of the Expressions of BRCA1 and p53 Predicts Poor Prognosis in Triple-Negative Breast Cancer.

Kim MC, Choi JE, Lee SJ, Bae YK. Kim MC, et al. Ann Surg Oncol. 2016 Oct;23(11):3524-3530. doi: 10.1245/s10434-016-5307-z. Epub 2016 Jun 8. Ann Surg Oncol. 2016. PMID: 27278204

10

A Nationwide Study on HER2-Low Breast Cancer in South Korea: Its Incidence of 2022 Real World Data and the Importance of Immunohistochemical Staining Protocols.

Kim MC, Cho EY, Park SY, Lee HJ, Lee JS, Kim JY, Lee HC, Yoo JY, Kim HS, Kim B, Kim WS, Shin N, Maeng YH, Kim HS, Kwon SY, Kim C, Jun SY, Kwon GY, Choi HJ, Lee SM, Choi JE, An AR, Choi HJ, Kim E, Kim A, Kim JY, Shim JY, Gong G, Bae YK. Kim MC, et al. Among authors: kim jy, kim e, kim b, kim a, kim c, kim hs, kim ws. Cancer Res Treat. 2024 Oct;56(4):1096-1104. doi: 10.4143/crt.2024.092. Epub 2024 Mar 6. Cancer Res Treat. 2024. PMID: 38453273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,197 results

Search Page

Filters